Girentuximab

Item number	Size	Delivery time	Price
TGM-T76684-1mg	1 mg	7 - 10 business days*	220.00€
TGM-T76684-5mg	5 mg	7 - 10 business days*	585.00€
TGM-T76684-10mg	10 mg	7 - 10 business days*	942.00€
TGM-T76684-100mg	100 mg	7 - 10 business days*	2,532.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal... more

Close menu

Product information "Girentuximab"

Description: Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP). Target: Carbonic Anhydrase. References: Chamie K, et al. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial. JAMA Oncol. 2017,3(7):913-920.

Keywords:	WX-G250, G250, cG250
Supplier:	TargetMol
Supplier-Nr:	T76684

Properties

Conjugate:

Database Information

KEGG ID :	K01672 \| Matching products
UniProt ID :	Q16790 \| Matching products
Gene ID :	GeneID 768 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Girentuximab"

Write a review